-
1 Comment
Karex Berhad is currently in a long term downtrend where the price is trading 30.0% below its 200 day moving average.
From a valuation standpoint, the stock is 75.1% cheaper than other stocks from the Other sector with a price to sales ratio of 1.6.
Karex Berhad's total revenue rose by 6.1% to $116M since the same quarter in the previous year.
Its net income has increased by 2631.4% to $3M since the same quarter in the previous year.
Finally, its free cash flow grew by 161.2% to $890K since the same quarter in the previous year.
Based on the above factors, Karex Berhad gets an overall score of 4/5.
Exchange | KLSE |
---|---|
Sector | Consumer Defensive |
Industry | Household & Personal Products |
CurrencyCode | MYR |
ISIN | MYL5247OO001 |
Market Cap | 806M |
---|---|
PE Ratio | 76.5 |
Beta | 1.04 |
Target Price | 1.05 |
Dividend Yield | 2.6% |
Karex Berhad, an investment holding company, manufactures and sells condoms in Malaysia. The company offers personal lubricants; probe covers; and catheters for transurethral drainage of the urinary bladder, as well as gloves. It also offers hand sanitizer and pre-vulcanised latex products. In addition, the company engages in wholesale healthcare product related business. Karex Berhad operates in the Americas, Asia, Europe, and Africa. Karex Berhad serves brand owners, governments, non-governmental organizations, and retail purchasers. The company was founded in 1988 and is based in Port Klang, Malaysia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 5247.KLSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025